Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Equity: 2020-2024

Historic Return on Equity for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to -0.19%.

  • Eton Pharmaceuticals' Return on Equity rose 9.00% to -0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.28%, marking a year-over-year increase of 9.00%. This contributed to the annual value of -0.19% for FY2024, which is 13.00% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Return on Equity stood at -0.19% for FY2024, which was down 192.27% from -0.07% recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Return on Equity ranged from a high of -0.07% in FY2023 and a low of -2.13% during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Return on Equity had a median value of -0.19% in 2024 and averaged -0.28%.
  • In the last 5 years, Eton Pharmaceuticals' Return on Equity spiked by 202bps in 2021 and then plummeted by 47bps in 2022.
  • Eton Pharmaceuticals' Return on Equity (Yearly) stood at -2.13% in 2020, then spiked by 202bps to -0.12% in 2021, then plummeted by 47bps to -0.59% in 2022, then skyrocketed by 52bps to -0.07% in 2023, then declined by 13bps to -0.19% in 2024.